• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23332 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2024     NIHR Health and Social Care Delivery Program Interventions to minimise hospital winter pressures related to discharge planning and integrated care: a rapid mapping review of UK evidence
2024     Penn Medicine Center for Evidence-based Practice (CEP) Urinary catheterization for epidural anesthesia in obstetrics
2024     NIHR Health and Social Care Delivery Program The Resilience Hub approach for addressing mental health of health and social care workers during the COVID-19 pandemic: a mixed-methods evaluation
2024     NIHR Health and Social Care Delivery Program Understanding and using experiences of social care to guide service improvements: translating a co-design approach from health to social care
2024     NIHR Health and Social Care Delivery Program Improving the integration of care for trans adults: ICTA a mixed-methods study
2024     NIHR Health and Social Care Delivery Program Preventing recurrence of endometriosis-related pain by means of long-acting progestogen therapy: the PRE-EMPT RCT
2024     NIHR Health and Social Care Delivery Program The UK resuscitative endovascular balloon occlusion of the aorta in trauma patients with life-threatening torso haemorrhage: the (UK-REBOA) multicentre RCT
2024     NIHR Health and Social Care Delivery Program Chair-based yoga programme for older adults with multimorbidity: RCT with embedded economic and process evaluations
2024     NIHR Health and Social Care Delivery Program Behaviour change intervention (education and text) to prevent dental caries in secondary school pupils: BRIGHT RCT, process and economic evaluation
2024     NIHR Health and Social Care Delivery Program Hyperthermic intraoperative peritoneal chemotherapy and cytoreductive surgery for people with peritoneal metastases: a systematic review and cost-effectiveness analysis
2024     NIHR Health and Social Care Delivery Program Artificial intelligence software for analysing chest X-ray images to identify suspected lung cancer: an evidence synthesis early value assessment
2024     NIHR Health and Social Care Delivery Program Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis
2024     NIHR Health and Social Care Delivery Program Community-based complex interventions to sustain independence in older people, stratified by frailty: a systematic review and network meta-analysis
2024     NIHR Health and Social Care Delivery Program Development and validation of prediction models for fetal growth restriction and birthweight: an individual participant data meta-analysis
2024     NIHR Health and Social Care Delivery Program Real-time ultrasound elastography in the diagnosis of newly identified thyroid nodules in adults: the ElaTION RCT
2024     NIHR Health and Social Care Delivery Program Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT
2024     NIHR Health and Social Care Delivery Program Feasibility of in-home monitoring for people with glaucoma: the I-TRAC mixed-methods study
2024     NIHR Health and Social Care Delivery Program The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluation
2024     NIHR Health and Social Care Delivery Program Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT
2024     NIHR Health and Social Care Delivery Program Gynaecological cancer surveillance for women with Lynch syndrome: systematic review and cost-effectiveness evaluation
2024     NIHR Health Technology Assessment programme Cerclage suture type to prevent pregnancy loss in women requiring a vaginal cervical cerclage: the C-STICH RCT
2024     NIHR Health Services and Delivery Research programme Signposting services for people with health and care needs: a rapid realist review
2024     NIHR Health Services and Delivery Research programme Why do acute healthcare staff behave unprofessionally towards each other and how can these behaviours be reduced? A realist review
2024     NIHR Health Technology Assessment programme Impact of Social Stories on social and emotional health of autism spectrum primary school children: the ASSSIST2 RCT with economic evaluation
2024     NIHR Health Services and Delivery Research programme Developing feasible person-centred care alternatives to emergency department responses for adults with epilepsy: a discrete choice analysis mixed-methods study
2024     NIHR Health Services and Delivery Research programme Health screening clinic to reduce absenteeism and presenteeism among NHS Staff: eTHOS a pilot RCT
2024     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Detection of IDH1 mutations in cholangiocarcinoma patients]
2024     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Decision support software in ultrasound diagnosis for the classification of breast nodules]
2024     NIHR Health Technology Assessment programme Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for advanced heart failure: systematic review and economic evaluation
2024     Institute for Clinical Effectiveness and Health Policy (IECS) [Endoscopic full thickness resection of colorectal lesions]
2024     Institute for Clinical Effectiveness and Health Policy (IECS) [Dupilumab in uncontrolled severe asthma]
2024     Institute for Clinical Effectiveness and Health Policy (IECS) [Bulking agents for stress urinary incontinence in women]
2024     NIHR Health Technology Assessment programme Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis
2024     NIHR Health Technology Assessment programme Nurse-delivered sleep restriction therapy to improve insomnia disorder in primary care: the HABIT RCT
2024     NIHR Health Services and Delivery Research programme Strengthening open disclosure in maternity services in the English NHS: the DISCERN realist evaluation study
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: evaluation of intensive behavioural intervention (EIBI) for preschool-age autistic children in Québec]
2024     WorkSafeBC Efficacy/effectiveness of orexin antagonists in treating insomnia associated with TBI
2024     WorkSafeBC Causal relationship between bilateral ankle fusion and bilateral knee osteoarthritis
2024     WorkSafeBC Causal association between IBS and COVID-19
2024     WorkSafeBC Effectiveness of ESWT in treating greater trochanteric bursitis
2024     WorkSafeBC Association between working in the flood and fire restoration industry and the development of prostate cancer
2024     WorkSafeBC Potential health effects of training fuel on firefighters
2024     WorkSafeBC Efficacy effectiveness of Axogen products to treat post-neuroma excision
2024     WorkSafeBC Causal association between firefighting and atrial fibrillation and or atrial flutter
2024     WorkSafeBC Guanfacine, micronized PEA, or amygdala and insula retraining programs as treatment for long COVID
2024     WorkSafeBC Current perception threshold (CPT) as a quantitative sensory testing (QST) method in hand-arm vibration syndrome (HAVS)
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: intra-abdominal infections in adults]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: diagnostic, prognostic, or predictive multigene panel for non-small cell lung carcinoma (NSCLC) by liquid biopsy (NGS)]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: next-generation sequencing (NGS) panels for intellectual disability or global developmental delays]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: updated recommendations for adjusting antidiabetic medication in type 2 diabetes]
2024     Health Information and Quality Authority (HIQA) Rapid health technology assessment of immunisation against respiratory syncytial virus (RSV) in Ireland
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: optimal modalities for organizing and delivering care and services related to radical cystectomy in Quebec]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: Quebec portrait of bladder cancer incidence, radical cystectomy practice, and resulting clinical outcomes]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: principles and criteria to guide the use of genome-wide sequencing versus targeted sequencing of a limited number of genes for the search of germline variants ]
2024     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Balloon pulmonary angioplasty for the branches of the artery pulmonary vessel]
2024     Austrian Institute for Health Technology Assessment (AIHTA) Stereotactic radiotherapy, proton therapy and irreversible electroporation for the treatment of localised prostate cancer (Update 2024)
2024     Austrian Institute for Health Technology Assessment (AIHTA) Renal denervation (RDN) in patients with treatment resistant hypertension. 2nd Update
2024     Austrian Institute for Health Technology Assessment (AIHTA) Percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB) in patients with coronary artery disease (CAD). 3rd Update
2024     Austrian Institute for Health Technology Assessment (AIHTA) Thermoablation for benign thyroid nodules
2024     Austrian Institute for Health Technology Assessment (AIHTA) Electroconvulsive therapy in treatment-resistant depression and treatment-resistant schizophrenia
2024     Austrian Institute for Health Technology Assessment (AIHTA) Caval valve implantation (CAVI) for severe tricuspid regurgitation
2024     Austrian Institute for Health Technology Assessment (AIHTA) Point of care tests (POCT): D-dimer and troponin (Update 2024)
2024     Austrian Institute for Health Technology Assessment (AIHTA) [Skin cancer prevention: Guideline recommendations for primary and secondary prevention]
2024     Austrian Institute for Health Technology Assessment (AIHTA) [CAR-based immunotherapy with a focus on CAR-NK cells]
2024     Austrian Institute for Health Technology Assessment (AIHTA) [Use of telepathology for intraoperative frozen section examination]
2024     Institute for Clinical Effectiveness and Health Policy (IECS) [Ketogenic diet in drug-resistant epilepsy]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge : optimal modalities for organizing and delivering care and services related to radical cystectomy in Quebec]
2024     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism by MS/MS. Update and assessment regional programs. Methylmalonic acidemias and propionic acidemia]
2024     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Effectiveness and safety of robotic-assisted orthopedic surgery for knee and hip arthroplasty]
2024     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Intraoperative Radiation Therapy for Breast Cancer]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of adding two genetic variants of Zellweger spectrum disorder to the carrier testing offer for people from the Saguenay-Lac-Saint-Jean, Charlevoix, and Haute-Côte-Nord regions]
2024     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Assesment of artificial intelligence´s diagnostic yield and security in cardiac monitoring using insertable cardiac monitors]
2024     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Diagnostic accuracy of impulse oscillometry (IOS) compared to spirometry]
2024     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Radiofrequency echographic multi-spectrometry for bone mineral density assessment]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of adding a genetic variant of mucolipidosis type II to the carrier testing offer for people from the Saguenay-Lac-Saint-Jean, Charlevoix, and Haute-Côte-Nord regions]
2024     Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) Tunstall TSP – a system for receiving and processing personal alarm alerts
2024     Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) MoodPilot® digital diary
2024     Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) DentView – a digital self-care guidance tool for oral health
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: carrier screening - disease selection, considerations, and ethical, psychosocial, sociocultural, organizational, and economic issues]
2024     Penn Medicine Center for Evidence-based Practice (CEP) Locking solutions for central venous catheters: 2024 update
2024     Penn Medicine Center for Evidence-based Practice (CEP) Communication interventions in healthcare that consider race and ethnicity
2024     Institute for Clinical Effectiveness and Health Policy (IECS) [Iontophoresis for primary palmar and plantar hyperhidrosis]
2024     Institute for Clinical Effectiveness and Health Policy (IECS) [Artificial urinary sphincter post-prostatectomy]
2024     Institute for Clinical Effectiveness and Health Policy (IECS) [Hybrid-knife endoscopic submucosal dissection]
2024     Institute for Clinical Effectiveness and Health Policy (IECS) [Extracorporeal membrane oxygenation for acute respiratory distress syndrome and lung transplantation in adults]
2024     Canary Health Service [Cost-effectiveness of universal vaccination against pneumococcal disease with the new conjugate vaccines against 15 and 20 serotypes]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: evaluation of STAT1 phosphorylation status by flow cytometry]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: initial evaluation of lung cancer patients for whom surgery is the first treatment – portrait of the situation in Québec from 2016 to 2019]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Elranatamab (multiples Myelom) - Addendum zum Projekt A24-12]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Polatuzumab vedotin (relapsed or refractory DLBCL) – Addendum to Project A23-140]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Omaveloxolone (Friedreich’s ataxia) – Assessment according to §35a (para. 1, sentence 11) Social Code Book V]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Rozanolixizumab (myasthenia gravis) – Assessment according to §35a (para. 1, sentence 11) Social Code Book V]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Transcutaneous vagus nerve stimulation in pharmacoresistant epilepsy – Second addendum to Commission E16-03]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Transcutaneous vagus nerve stimulation in pharmacoresistant epilepsy - Addendum to Commission E16-03]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Transcutaneous vagus nerve stimulation in pharmacoresistant epilepsy]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Measurement and monitoring of pulmonary arterial pressure by means of implanted sensor for treatment optimization in heart failure stage NYHA III - Addendum to Project D23-02]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Routine practice data collection for talquetamab (multiple myeloma) - First addendum to Project A23-100]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Polatuzumab vedotin (combination with rituximab, cyclophosphamide, doxorubicin and prednisone; previously untreated DLBCL) – Addendum to Project A23-141]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dostarlimab (endometrial cancer) - Addendum to Project A23-143]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pembrolizumab (gastric and gastro-oesophageal junction adenocarcinoma, HER2-positive) – Addendum to Project A24-01]